文献速递颈动脉与弓上血管

颈动脉干预治疗眼部症状后的神经眼科结局

Neuro-ophthalmic outcomes after carotid intervention for ocular symptoms.
PubMed 文献 · J Vasc Surg · 2024-11-19

回顾性分析2018年1月至2022年12月因视网膜缺血接受颈动脉干预的连续患者90例,分为一过性黑矇/血管性短暂单眼视力丧失组、眼缺血综合征组和视网膜中央/分支动脉阻塞组。结果显示颈动脉内膜切除和颈动脉支架术后同侧症状复发率低,早期眼缺血综合征(伴短暂症状)干预与症状缓解和预防永久性视力丧失相关。

要点

  • 90例视网膜缺血患者接受颈动脉干预,中位随访38.5个月(范围0-207个月)。
  • 第一组无短暂或永久性视网膜缺血事件复发。
  • 眼缺血综合征伴短暂症状者7例中5例症状和眼部体征缓解。

核心结论

  • 颈动脉干预治疗视觉症状后的神经眼科结局良好,颈动脉内膜切除和颈动脉支架术后症状性复发率低。
  • 早期发现眼缺血综合征(伴短暂症状)时进行干预与症状缓解和预防永久性视力丧失相关。

研究设计与样本

  • 回顾性综述,纳入2018年1月至2022年12月因视网膜缺血接受颈动脉干预的连续患者90例(70例男性,年龄75±9岁)。
  • 患者分为三组:第一组为一过性黑矇/血管性短暂单眼视力丧失31例(34%),第二组为眼缺血综合征7例(8%),第三组为视网膜中央/分支动脉阻塞52例(58%)。

主要发现

  • 干预方式:颈动脉内膜切除64例(71%),经股动脉颈动脉支架21例(23%),经颈动脉血运重建4例(4%),颈动脉旁路1例(1%)。
  • 第一组无短暂或永久性视网膜缺血事件复发。
  • 第二组7例伴短暂症状的眼缺血综合征患者中5例症状和眼部体征缓解;2例伴永久性视力丧失者无改善但症状无恶化;第三组2例报告视力下降。
  • 全组5年同侧卒中率为2%;1年和5年生存率分别为93%和82%,组间无差异(P<.05)。
  • 术后30天内1例死于支架血栓继发的缺血性卒中(第三组),其余队列无长期脑血管病死亡。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The long-term neuro-ophthalmic outcomes after carotid intervention in patients presenting with preoperative visual symptoms vary widely based on the underlying etiology of retinal ischemia and are not well understood. METHODS: We performed a retrospective review of consecutive patients presenting with retinal ischemia who subsequently underwent carotid intervention from January 2018 to December 2022. Patients were classified into three groups (group I: amaurosis fugax/vascular transient monocular vision loss, group II: ocular ischemic syndrome [OIS], and group III: central/branch retinal artery occlusion). Clinical details and the nature of visual symptoms were recorded. Outcomes analyzed were ipsilateral symptom recurrence, visual improvement, stroke rate, and survival. RESULTS: A total of 90 patients were included in this study (70 male, aged 75 ± 9 years): 31 patients (34%) in group I (amaurosis fugax), 7 patients (8%) in group II (OIS), and 52 patients (58%) in group III central/branch retinal artery occlusion. Atherosclerotic risk factors were similar across groups with similar preoperative antiplatelet and statin use. Interventions performed were carotid endarterectomy in 64 (71%), transfemoral carotid artery stenting in 21 (23%), transcarotid artery revascularization in 4 (4%), and carotid artery bypass in 1 patient (1%). The median follow-up was 38.5 months (range: 0-207 months). There was no recurrence of transient or permanent retinal ischemic events in any patient in group I. In group II, 5 of 7 patients presenting with transient symptoms of OIS showed resolution of symptoms and ocular signs. Two patients presenting with permanent vision loss in group II had no improvement but no worsening symptoms, and visual decline was reported in two patients in group III. Ipsilateral stroke rate was 2% at 5 years for the entire group. Survival was 93% and 82% at 1 and 5 years, respectively, with no difference between groups (P < .05). There was one postoperative death from ischemic stroke secondary to stent thrombosis within 30 days (group III), with no long-term mortality from cerebrovascular disease in the rest of the cohort. CONCLUSIONS: Neuro-ophthalmic outcomes after carotid intervention for visual symptoms are favorable with low symptomatic recurrence after both carotid endarterectomy and carotid artery stenting. Intervention for OIS when detected early (with transient symptoms) is associated with resolution of symptoms and prevention of permanent visual loss.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Al Ibraheem B, Tallarita T, Mansukhani SA, et al. Neuro-ophthalmic outcomes after carotid intervention for ocular symptoms. J Vasc Surg. 2024. PMID: 39571921. doi:10.1016/j.jvs.2024.11.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。